Core Viewpoint - Enwei Pharmaceutical (301331.SZ) has signed a partnership agreement with several entities to invest in a fund, aiming to leverage professional investment resources to enhance competitiveness and investment efficiency [1] Group 1: Investment Details - The company will invest RMB 20 million as a limited partner, representing a 9.9502% stake in the investment fund [1] - The partnership includes Shanghai Panlin Hongyu Enterprise Management Partnership (Limited Partnership), Tangshan Jinkun Chemical Co., Ltd., and Li Jiao Jiao [1] Group 2: Strategic Objectives - The investment aims to utilize the advantages of professional investment institutions in the equity investment field while controlling risks [1] - The initiative is expected to help the company identify and position itself in strategic emerging industries and future sectors conducive to long-term development [1]
恩威医药(301331.SZ)拟出资2000万元投资嘉兴磐霖嘉颐创业投资合伙企业